UnitedHealth Group Incorporated $UNH Holdings Decreased by GUARDCAP ASSET MANAGEMENT Ltd

GUARDCAP ASSET MANAGEMENT Ltd trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 829,546 shares of the healthcare conglomerate’s stock after selling 150,723 shares during the quarter. UnitedHealth Group accounts for about 7.3% of GUARDCAP ASSET MANAGEMENT Ltd’s holdings, making the stock its 5th largest holding. GUARDCAP ASSET MANAGEMENT Ltd’s holdings in UnitedHealth Group were worth $273,851,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the company. PARUS FINANCE UK Ltd raised its holdings in shares of UnitedHealth Group by 15.9% during the 4th quarter. PARUS FINANCE UK Ltd now owns 28,110 shares of the healthcare conglomerate’s stock valued at $9,279,000 after buying an additional 3,850 shares in the last quarter. Verity & Verity LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $1,065,000. Texas Yale Capital Corp. grew its position in UnitedHealth Group by 78.6% during the 4th quarter. Texas Yale Capital Corp. now owns 6,200 shares of the healthcare conglomerate’s stock worth $2,047,000 after acquiring an additional 2,728 shares during the last quarter. Impact Partnership Wealth LLC grew its position in UnitedHealth Group by 15.9% during the 4th quarter. Impact Partnership Wealth LLC now owns 2,525 shares of the healthcare conglomerate’s stock worth $834,000 after acquiring an additional 347 shares during the last quarter. Finally, Koss Olinger Consulting LLC grew its position in UnitedHealth Group by 5.3% during the 4th quarter. Koss Olinger Consulting LLC now owns 1,032 shares of the healthcare conglomerate’s stock worth $341,000 after acquiring an additional 52 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.7%

NYSE UNH opened at $379.70 on Friday. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $404.15. The firm has a market capitalization of $344.82 billion, a PE ratio of 28.68, a P/E/G ratio of 1.64 and a beta of 0.64. The stock’s 50 day moving average is $336.85 and its 200 day moving average is $321.55.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The company had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. During the same period in the previous year, the company posted $7.20 earnings per share. The firm’s revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current fiscal year.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealthcare said it will eliminate prior authorization requirements for nearly two-thirds of pediatric services by year-end. That could reduce administrative friction, improve patient/provider relations, and support customer satisfaction. Reuters article
• Positive Sentiment: Bernstein raised its price target on UNH to $492 from $444 and kept an Outperform rating, citing an EPS recovery outlook. Higher price targets from analysts can help reinforce investor confidence. Yahoo Finance article
• Neutral Sentiment: Berkshire Hathaway fully exited its UNH stake, which is drawing attention to valuation and regulatory risks. While not necessarily a fundamental change, the sale may weigh on sentiment around the stock. Yahoo Finance article
• Negative Sentiment: Massachusetts filed a lawsuit against a UnitedHealth insurance unit, alleging more than $100 million in Medicaid fraud tied to inflated illness severity claims. The lawsuit adds legal and reputational risk for UNH. Investing.com article

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.28% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on UNH shares. Wells Fargo & Company raised their price target on UnitedHealth Group from $370.00 to $397.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 22nd. Weiss Ratings upgraded UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Royal Bank Of Canada lifted their price objective on UnitedHealth Group from $361.00 to $400.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Mizuho lifted their price objective on UnitedHealth Group from $410.00 to $440.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 20th. Finally, TD Cowen lifted their price objective on UnitedHealth Group from $311.00 to $337.00 and gave the stock a “hold” rating in a research report on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $397.63.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.